Escitalopram Oxalate price index

Escitalopram Oxalate price December 2025 and outlook (see chart below)

• India:US$136.46/KG, 0.1% up

Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.

Escitalopram Oxalate price index

This post is a summary of the Escitalopram Oxalate price developments. The price developments of Escitalopram Oxalate are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Escitalopram Oxalate price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.

The outlook for Escitalopram Oxalate prices is generated from different inputs including:

• Very recent price developments of immediate cost drivers of Escitalopram Oxalate prices
• Recent price developments of underlying feedstocks which drive the price of Escitalopram Oxalate
• Market futures for both cost drives and feedstocks of Escitalopram Oxalate prices
• Adjustment of current supply/demand imbalances in the Escitalopram Oxalate market
• Longer term trends in likely demand conditions

What is Escitalopram Oxalate and what is it used for

Escitalopram oxalate is the oxalate salt form of escitalopram, the S-enantiomer of citalopram — a selective serotonin reuptake inhibitor (SSRI). It increases synaptic serotonin by inhibiting the serotonin transporter (SERT) and is approved to treat major depressive disorder and several anxiety disorders (for example generalized anxiety disorder, panic disorder, social anxiety disorder and in some regions obsessive-compulsive disorder). Clinically it is widely regarded as an effective and well-tolerated SSRI.

How is Escitalopram Oxalate produced

Commercial production is chemical: organic synthesis yields the citalopram intermediate which is resolved to the S-enantiomer (escitalopram). The active base is commonly converted to its oxalate salt for isolation, purification and improved handling. Several industrial processes and patents describe steps such as formation of a diol intermediate, resolution of enantiomers, cyclization and formation/crystallization of the oxalate salt, followed by downstream purification and milling to API specification. Process development literature and granted patents detail routes and impurity control used at scale.

How large is the global market for Escitalopram Oxalate and where is it produced

Market research reports estimate the global market for escitalopram/escitalopram oxalate (finished formulations and API market estimates vary by study) in the low-to-mid billions USD range — several reports place the market around USD ~1.0–1.5 billion in the early 2020s with multi-year projections showing growth (single-digit CAGRs) depending on the forecast and segmentation. Because market estimates differ by publisher and whether they count finished-product sales versus API value, treat reported figures as approximate and source-dependent.

Production of the active pharmaceutical ingredient (API) and finished escitalopram products is global but concentrated in major generic-manufacturing hubs — notably India and China — alongside originator/regional producers (for example Lundbeck historically developed escitalopram). Supplier directories and pharmacopeial listings show many API manufacturers and exporters based in India and China, with additional finished-product manufacture in Europe, North America and other Asian countries depending on the brand and regulatory filings.